NASDAQ:SRTS Sensus Healthcare (SRTS) Stock Price, News & Analysis $2.83 -0.12 (-4.07%) As of 01:19 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Sensus Healthcare Stock (NASDAQ:SRTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sensus Healthcare alerts:Sign Up Key Stats Today's Range$2.81▼$2.9050-Day Range$2.75▼$3.5452-Week Range$2.66▼$5.49Volume15,093 shsAverage Volume57,418 shsMarket Capitalization$46.58 millionP/E RatioN/ADividend YieldN/APrice Target$5.83Consensus RatingModerate Buy Company Overview Sensus Healthcare, Inc. is a medical device company focused on non-invasive treatment technologies for dermatologic and oncologic conditions. The company develops and commercializes superficial radiotherapy systems designed to deliver low-energy X-rays to targeted areas of the skin. Its principal products include the SRT-100 and SRT-100 Vision systems, which are used by physicians to treat non-melanoma skin cancers, including basal cell and squamous cell carcinomas, as well as keloids. The systems are intended to provide an alternative to certain surgical procedures and are used in dermatology, radiation oncology and other clinical settings. Founded in 2010, Sensus Healthcare is headquartered in Boca Raton, Florida. The company markets its products primarily through a combination of direct sales and distribution relationships in the United States and selected international markets. Joseph C. Sardano has served as the company’s chairman and chief executive officer.AI Generated. May Contain Errors. Read More Sensus Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreSRTS MarketRank™: 2.90828042685 of 5 starsSensus Healthcare scored higher than 58% of companies evaluated by MarketBeat, and ranked 513th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingModerate Buy Consensus RatingSensus Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialSensus Healthcare has a consensus price target of $5.83, representing about 104.0% upside from its current price of $2.86.Amount of Analyst CoverageSensus Healthcare has only been the subject of 3 research reports in the past 90 days.Read more about Sensus Healthcare's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is -3.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is -3.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Sensus Healthcare's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.54% of the float of Sensus Healthcare has been sold short.Short Interest Ratio / Days to CoverSensus Healthcare has a short interest ratio ("days to cover") of 7.84.Change versus previous monthShort interest in Sensus Healthcare has recently increased by 0.16%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for SRTS on MarketBeat in the last 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $405,230.00 in company stock, which represents 0.8608% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $405,230.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.20% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions25.30% of the stock of Sensus Healthcare is held by institutions.Read more about Sensus Healthcare's insider trading history. Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRTS Stock News HeadlinesSensus Healthcare IncAugust 31, 2026 | money.usnews.comSensus (SRTS) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | finance.yahoo.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 26 at 1:00 AM | Weiss Ratings (Ad)Sensus outlines shift to $250,000 average selling price as it targets a stronger second halfAugust 14, 2026 | seekingalpha.comSensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comSensus Healthcare Reports Second Quarter 2026 Financial Results and Business HighlightsAugust 13, 2026 | businesswire.comSensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026July 30, 2026 | businesswire.comSensus Healthcare Secures New $15 Million Credit FacilityJune 5, 2026 | tipranks.comSee More Headlines SRTS Stock Analysis - Frequently Asked Questions How have SRTS shares performed this year? Sensus Healthcare's stock was trading at $3.98 on January 1st, 2026. Since then, SRTS shares have decreased by 28.1% and is now trading at $2.86. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) announced its quarterly earnings results on Thursday, August, 13th. The company reported ($0.53) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.41. The company had revenue of $2.29 million for the quarter, compared to analyst estimates of $4.60 million. Sensus Healthcare had a negative trailing twelve-month return on equity of 21.57% and a negative net margin of 88.45%. Read the conference call transcript. When did Sensus Healthcare IPO? Sensus Healthcare (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. How do I buy shares of Sensus Healthcare? Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Palantir Technologies (PLTR), Tesla (TSLA), Ford Motor (F), Teladoc Health (TDOC) and AbbVie (ABBV). Company Calendar Last Earnings8/13/2026Today10/26/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 11 days, SRTS's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SRTS CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees60Year Founded2010Price Target and Rating Average Price Target for Sensus Healthcare$5.83 High Price Target$7.50 Low Price Target$4.00 Potential Upside/Downside+106.1%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.72 million Net Margins-88.45% Pretax Margin-72.53% Return on Equity-21.57% Return on Assets-19.20% Debt Debt-to-Equity RatioN/A Current Ratio8.71 Quick Ratio4.30 Sales & Book Value Annual Sales$27.48 million Price / Sales1.70 Cash FlowN/A Price / Cash FlowN/A Book Value$2.93 per share Price / Book0.97Miscellaneous Outstanding Shares16,460,000Free Float14,783,000Market Cap$46.58 million OptionableOptionable Beta1.18 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:SRTS) was last updated on 10/26/2026 by MarketBeat.com Staff. From Our PartnersTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredFederal Reserve’s Disturbing Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredBeginner’s Guide to GoldInflation, trade wars, and market volatility have many savers rethinking how they protect retirement funds. A ...Goldco Direct, LLC | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredAnd they say the headline number understates what’s really happening.Goldman Sachs just admitted it underestimated central bank gold purchases by more than 500 percent, with buyin...Cedar Gold Group | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
